,

Rev Esp Quimioter 2020; 33(1):85-86

Estrategias para la mejora de la prescripción del tratamiento antibiótico en Urgencias  

(Strategies for improving the antibiotic treatment prescription in the Emergency Department)

EVA ORVIZ, PABLO JEREZ-FERNÁNDEZ, MIGUEL SUAREZ-ROBLES, CLARA RAMOS-REY, INÉS ARMENTEROS, MARÍA FERNÁNDEZ-REVALDERÍA, JUAN GONZÁLEZ DEL CASTILLO

http://www.doi.org/10.37201/req/102.2019

CARTA AL DIRECTOR

Rev Esp Quimioter 2020; 33(1):85-86 [Texto completo PDF]

Keywords: Emergency; empiric treatment, microbiological diagnosis; multidrug resistant bacteria

 

/por
,

Rev Esp Quimioter 2020; 33(1):49-67

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document  

EMILIO BOUZA, AGUSTÍ ALVAR, PERE ALMAGRO, TAMARA ALONSO, JULIO ANCOCHEA, FERRÁN BARBÉ, JOSEP CORBELLA, DIEGO GRACIA, ENRIQUE MASCARÓS, JOAN MELIS, MARC MIRAVITLLES, MARIANO PASTOR, PATRICIA PÉREZ, DAVID RUDILLA, ANTONI TORRES, JOAN BAUTISTA SORIANO, ANTONI VALLANO, FRANCISCO VARGAS, ESTEBAN PALOMO

http://www.doi.org/10.37201/req/2064.2019

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases in the World, and one of the most important causes of mortality and morbidity. In adults 40 years and older, it affects more than 10% of the population and has enormous personal, family and social burden. Tobacco smoking is its main cause, but not the only one, and there is probably a genetic predisposition that increases the risk in some patients. The paradigm of this disease is changing in Spain, with an increase of women that has occurred in recent years. Many of the physio pathological mechanisms of this condition are well known, but the psychological alterations to which it leads, the impact of COPD on relatives and caregivers, the limitation of daily life observed in these patients, and the economic and societal burden that they represent for the health system, are not so well-known. A major problem is the high under-diagnosis, mainly due to difficulties for obtaining, in a systematic way, spirometries in hospitals and health-care centers. For this reason, the Fundación de Ciencias de la Salud and the Spanish National Network Center for Research in Respiratory Diseases (CIBERES) have brought together experts in COPD, patients and their organizations, clinical psychologists, experts in health economics, nurses and journalists to obtain their opinion about COPD in Spain. They also discussed the scientific bibliometrics on COPD that is being carried out from the CIBERES and speculated on the future of this condition. The format of the meeting consisted in the discussion of a series of questions that were addressed by different speakers and discussed until a consensus conclusion was reached.

Rev Esp Quimioter 2020; 33(1):49-67 [Full-text PDF]

/por
,

Rev Esp Quimioter 2020; 33(1):68-72

Helicobacter pylori infection in the HIV + population: a comorbidity to think about   

Mª EULALIA VALENCIA, ROCÍO MONTEJANO, VICTORIA MORENO, LUZ MARTÍN CARBONERO, JOSÉ IGNACIO BERNARDINO, LUCÍA SERRANO

http://www.doi.org/10.37201/req/033.2019

Introduction. Gastrointestinal disorders are frequent in HIV+. Helicobacter pylori may be an underdiagnosed cause.
Material and methods. Patients with HIV and H. pylori were described since January 1998 up to December 2017.
Results. A total de 132 patients were included. The most frequent symptom was dyspepsia. 88.5% had chronic atrophic gastritis. Eradication was achieved in 102 (77.3%). Healing was more frequent with quadruple regimen (p=0.004) and in the youngest (p=0.041).
Conclusion. H. pylori infection could be responsible for nonspecific digestive manifestations in HIV + patients.

Rev Esp Quimioter 2020; 33(1):68-72 [Texto completo PDF]

/por
,

Rev Esp Quimioter 2020; 33(1):80-82

Decreased painful visual acuity. Corynebacterium macginleyi blebitis-endophthalmitis infection  

(Disminución de agudeza visual dolorosa. Blebitis-endoftalmitis infecciosa por Corynebacterium macginleyi)

LAURA TABUENCA DEL BARRIO, MARCOS MOZO CUADRADO, ENRIQUE BORQUE RODRÍGUEZ-MAIMÓN, ALICIA ZUBICOA ENERIZ, ANDRÉS GARRALDA LUQUÍN

doi:10.37201/req/070.2019

LETTER TO THE EDITOR

Rev Esp Quimioter 2020; 33(1):80-82 [Full-text PDF]

Keywords: Blebitis-endophthalmitis; Corynebacterium macginleyi; trabeculectomy.

 

/por
,

Rev Esp Quimioter 2020; 33(1):78-79

Prevención de la enfermedad neumocócica invasiva en el paciente asplénico 

(Invasive pneumococcal infection prevention in asplenic patients)

JUAN RODRÍGUEZ-GARCÍA, RAFAEL FERNÁNDEZ-SANTOS, ENRIQUE RUIZ DE GOPEGUI-BORDES, OLGA HIDALGO-PARDO

http://www.doi.org/10.37201/req/065.2019

LETTER TO THE EDITOR

Rev Esp Quimioter 2020; 33(1):78-79 [Texto completo PDF]

Keywords: Immunization, Vaccines, Infection, Streptococcus pneumoniae, Splenic Diseases;

 

/por
,

Rev Esp Quimioter 2020; 33(1):83-84

Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates    

(Uso del pocillo de colistina del sistema Microscan WalkAway para la determinación de la sensibilidad de aislados clínicos recientes de Pseudomonas aeruginosa y Acinetobacter baumannii)

JAIME BORREGO-JIMÉNEZ, CLAUDIA SORIA-SEGARRA, TEODORA DIANA MOLDOVAN, JOSÉ MARÍA NAVARRO-MARÍ, JOSÉ GUTIÉRREZ-FERNÁNDEZ

http://www.doi.org/10.37201/req/076.2019

LETTER TO THE EDITOR

Rev Esp Quimioter 2020; 33(1):83-84 [Full-text PDF]

Keywords: Pseudomonas aeruginosa, Acinetobacter baumannii, colistin.

 


/por
,

Rev Esp Quimioter 2020; 33(1):76-77

Infradiagnóstico de linfogranuloma venéreo   

(Underdiagnosis of lymphogranuloma venereum )

BERTA PINO CALM, LAURA MARTÍNEZ-GARCÍA, CONCEPCIÓN BELTRÁN TACORONTE, JULIA ALCOBA FLOREZ

http://www.doi.org/10.37201/req/061.2019

CARTA AL DIRECTOR

Rev Esp Quimioter 2020; 33(1):76-77 [Texto completo PDF]

Keywords: Chlamydia trachomatis, Lymphogranuloma venereum, ulcer, proctitis.

 

/por
,

Rev Esp Quimioter 2020; 33(1):73-75

Arcobacter butzleri and intestinal colonization    

(Arcobacter butzleri y colonización intestinal )

GEMMA JIMÉNEZ-GUERRA, ISABEL CASANOVAS MORENO-TORRES, TEODORA DIANA MOLDOVAN, JOSÉ MARÍA NAVARRO-MARÍ, JOSÉ GUTIÉRREZ-FERNÁNDEZ

http://www.doi.org/10.37201/req/060.2019

LETTER TO THE EDITOR

Rev Esp Quimioter 2020; 33(1):73-75 [Full-text PDF]

Keywords: Arcobacter butzleri, intestinal colonization

 

/por
,

Rev Esp Quimioter 2020; 33(1):44-48

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients  

TERESA VILLAESCUSA, LOURDES VÁZQUEZ, JUAN MIGUEL BERGUA, JULIO GARCÍA, ANTONIO ROMERO, M. TERESA OLAVE, DANIEL GARCÍA BELMONTE, M. PAZ QUEIPO DE LLANO, GRUPO DE INFECCIONES EN PACIENTES HEMATOLÓGICOS. SOCIEDAD ANDALUZA DE HEMATOLOGÍA Y HEMOTERAPIA.

http://www.doi.org/10.37201/req/067.2019

Introduction. Fungal infections are a major cause of morbidity and mortality in the haematological patients. These infections are mainly due to Candida spp. and Aspergillus spp. Mortality by these infections is high, but rates have descended in the latest series due to better antifungal agents. Echinocandins are, in vitro, very active against Candida and Aspergillus spp. The objective of the study is to analyse the efficacy and safety of micafungin in the antifungal prophylaxis of haematological patients on chemotherapy.
 Material and methods. A multicentre, observational retrospective study was performed in 7 Haematology Departments in Spain. Patients admitted to these departments with chemotherapy or immunosuppressive treatment, and who had received antifungal prophylaxis with micafungin between 1 January 2009 and 31 December 2014 were included.
Results. There were 5 cases of probable or proven fungal infection (4.8%) according to the 2008 EORTC criteria: 2 proven, 3 probable. The types of fungal infection were 3 aspergillosis and 2 candidiasis. There were no drop-outs from the prophylaxis with micafungin due to toxicity. .
Conclusion. Micafungin is an antifungal agent which, used in prophylaxis, has demonstrated good efficacy and an excellent toxicity profile, making it an apparently interesting option in patients requiring antifungal prophylaxis during their hospitalisation episode.

Rev Esp Quimioter 2020; 33(1):44-48 [Full-text PDF]

/por
,

Rev Esp Quimioter 2019; 32(6):571-576

Evaluación de la actividad investigadora en Microbiología: el papel de la Revista Española de Quimioterapia  

(Evaluation of research activity in Microbiology: the role of the Spanish Journal of Chemotherapy)

DAVID CARABANTES ALARCÓN, LUIS ALOU CERVERA

CARTA AL DIRECTOR

Rev Esp Quimioter 2019; 32(6):571-576 [Texto completo PDF]

Palabras clave: Sexenio de investigación, Journal Impact Factor, Journal Citation Reports, Impacto Normalizado, Highly Cited Researchers

Keywords: Six Year Research Period, Journal Impact Factor, Journal Citation Reports, Normalized Impact, Highly Cited Researchers

 


/por